NATALIE FISHER: Open Payments
NPI 1609209428 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 24 payments from 18 companies in 2025. Trend: 2023 $69 · 2024 $1,183 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $96 |
| GENZYME CORPORATION | 1 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Alexion Pharmaceuticals, Inc. | 2 | $48 |
| Pharmacosmos Therapeutics Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Janssen Scientific Affairs, LLC | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $24 |
| Tempus AI, Inc | 1 | $24 |
| Caris MPI, Inc. | 1 | $24 |
Products named: ICLUSIG, CABLIVI, PLUVICTO, ULTOMIRIS, MONOFERRIC, Nubeqa, ERLEADA, TALVEY.
Industry payments across FL — which companies pay providers there.
